ヒトミルクオリゴ糖（HMO）市場規模、シェア、成長分析：タイプ別、製品別、用途別、流通チャネル別、地域別 - 産業予測 2025～2032年

ヒトミルクオリゴ糖（HMO）市場規模は2023年に2億820万米ドルと評価され、2024年の2億2,964万米ドルから2032年には5億311万米ドルに成長し、予測期間（2025-2032年）のCAGRは10.3％で成長する見通しです。

ヒトミルクオリゴ糖（HMO）市場は、乳幼児の栄養と健康の重要な構成要素として牽引力を増しており、その無数の健康上の利点が認識されています。母乳中に天然に存在するHMOは、免疫系の成熟、胃腸の健康、および認知発達を促進します。研究が進むにつれて、HMOの潜在的用途は医薬品、機能性食品、プレバイオティクスサプリメントへと拡大しています。市場成長の主な促進要因には、HMOの健康上の利点に対する意識の高まりと乳児用調製粉乳をより母乳に近づけようとする動きが含まれます。しかしながら、HMO生産の複雑さと高コスト、規制と知的所有権の問題などの課題は依然として大きいです。それにもかかわらず、現在進行中の調査は、乳児栄養を強化するだけでなく、ライフサイクルを通したより広範な健康上の懸念に対処することを約束し、ヘルスケアと機能性食品におけるHMOの変革的未来を示しています。

目次

イントロダクション

• 調査の目的
• 調査範囲
• 定義

調査手法

• 情報調達
• 二次と一次データの方法
• 市場規模予測
• 市場の前提条件と制限

エグゼクティブサマリー

• 世界市場の見通し
• 供給と需要の動向分析
• セグメント別機会分析

市場力学と見通し

• 市場概要
• 市場規模
• 市場力学
  • 促進要因と機会
  • 抑制要因と課題
• ポーターの分析

主な市場の考察

• 重要成功要因
• 競合の程度
• 主な投資機会
• 市場エコシステム
• 市場の魅力指数（2024年）
• PESTEL分析
• マクロ経済指標
• バリューチェーン分析
• 価格分析

ヒトミルクオリゴ糖（HMO）市場規模：タイプ別& CAGR（2025-2032）

• 市場概要
• 2'FL
• 3'FL
• 3'SL
• 6'SL

ヒトミルクオリゴ糖（HMO）市場規模：製品別& CAGR（2025-2032）

• 市場概要
• フコシルラクトース
• ラクト-N-テトラオースとラクト-N-ネオテトラオース
• シアリルラクトース

ヒトミルクオリゴ糖（HMO）市場規模：用途別& CAGR（2025-2032）

• 市場概要
• 乳児用調製粉乳
• 機能性食品・飲料
• 栄養補助食品
• 人間と動物の健康成分
• その他

ヒトミルクオリゴ糖（HMO）市場規模：流通チャネル別& CAGR（2025-2032）

• 市場概要
• ハイパーマーケットとスーパーマーケット
• ドラッグストアまたは薬局
• 量販店
• 百貨店
• モノブランド店
• 専門店
• オンライン販売チャネル

ヒトミルクオリゴ糖（HMO）市場規模：地域別& CAGR（2025-2032）

• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • スペイン
  • フランス
  • 英国
  • イタリア
  • その他欧州地域
• アジア太平洋地域
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋地域
• ラテンアメリカ
  • ブラジル
  • その他ラテンアメリカ地域
• 中東・アフリカ
  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ

競合情報

• 上位5社の比較
• 主要企業の市場ポジショニング（2024年）
• 主な市場企業が採用した戦略
• 最近の市場動向
• 企業の市場シェア分析（2024年）
• 主要企業の企業プロファイル
  • 企業の詳細
  • 製品ポートフォリオ分析
  • 企業のセグメント別シェア分析
  • 収益の前年比比較（2022-2024）

主要企業プロファイル

• DSM（Netherlands）
• BASF SE（Germany）
• DuPont（US）
• Nestle（Switzerland）
• Inbiose NV（Belgium）
• Gnubiotics Sciences S.A（Switzerland）
• Abbott Laboratories（US）
• Royal FrieslandCampina N.V（Netherlands）
• Elicityl S.A（France）
• Dextra Laboratories（UK）
• Glycom A/S（Denmark）
• Glycosyn（US）
• Medolac Laboratories（US）
• Neolacta Lifesciences Pvt. Ltd.（India）
• Jennewein Biotechnologie GmbH（Germany）
• Lonza Specialty Ingredients（Switzerland）
• Kirin Holdings Company（Kyowa Hakko Bio）（Japan）
• ZuChem Inc.（US）

結論と提言

Human Milk Oligosaccharides (HMO) Market size was valued at USD 208.2 million in 2023 and is poised to grow from USD 229.64 million in 2024 to USD 503.11 million by 2032, growing at a CAGR of 10.3% during the forecast period (2025-2032).

The human milk oligosaccharides (HMO) market is gaining traction as a crucial component of infant nutrition and wellness, recognized for its myriad health benefits. Naturally occurring in breast milk, HMOs promote immune system maturation, gastrointestinal health, and cognitive development. As research advances, their potential applications are expanding into pharmaceuticals, functional foods, and prebiotic supplements. Key drivers of market growth include increasing awareness of HMOs' health benefits and the push to make infant formulas more akin to breast milk. However, challenges such as the complexity and high costs of HMO production, along with regulatory and intellectual property issues, remain significant. Nonetheless, ongoing research promises not only to enhance infant nutrition but also to address broader health concerns throughout the life cycle, indicating a transformative future for HMOs in healthcare and functional foods.

Top-down and bottom-up approaches were used to estimate and validate the size of the Human Milk Oligosaccharides (Hmo) market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Human Milk Oligosaccharides (Hmo) Market Segments Analysis

Global Human Milk Oligosaccharides (HMO) Market is segmented by Type, Product, Application, Distribution channel and region. Based on Type, the market is segmented into 2'FL, 3'FL, 3'SL and 6'SL. Based on Product, the market is segmented into Fucosyllactose, Lnt & LNnt and Sialyllactose. Based on Application, the market is segmented into Infant formula, Functional food & beverages, Food supplements, Health ingredients for human and animal and Other. Based on Distribution channel, the market is segmented into Hypermarkets and supermarkets, Drug store or pharmacy, Mass merchandiser, Departmental stores, Mono-brand stores, Specialty stores and Online sales channel. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Human Milk Oligosaccharides (Hmo) Market

The rising recognition of the health benefits associated with human milk oligosaccharides (HMOs) serves as a significant catalyst for the market's expansion. As consumers become more informed about how HMOs contribute to enhanced immune function, cognitive growth, and gastrointestinal health, especially in infants, the demand for products fortified with these beneficial compounds has surged. This increased interest not only reflects parents' desire to provide optimal nutrition for their children but also highlights potential advantages for adults, further driving market growth. Consequently, the HMO market is experiencing a robust uptick, fueled by escalating awareness of their nutritional advantages.

Restraints in the Human Milk Oligosaccharides (Hmo) Market

The Human Milk Oligosaccharides (HMO) market faces significant restraints due to the intricate and challenging nature of HMO synthesis. The complexity of the processes involved complicates the scalability of HMO production, making it more difficult to achieve cost-effective manufacturing. The diverse array of HMO structures found in breast milk necessitates sophisticated and expensive techniques for replication, further hindering the industry's ability to produce these valuable components efficiently. As a result, these factors may limit the widespread availability and affordability of HMOs, ultimately impacting market growth and accessibility for potential consumers and manufacturers alike.

Market Trends of the Human Milk Oligosaccharides (Hmo) Market

The Human Milk Oligosaccharides (HMO) market is witnessing a significant trend towards expanding applications beyond traditional infant nutrition. While HMOs have primarily been associated with breastfeeding, their potential is now being explored in various sectors, including functional foods, dietary supplements, and pharmaceutical products. This shift is driven by growing scientific research showcasing the health benefits of HMOs, such as immune support and gut health improvement, for individuals across different age groups. Consequently, manufacturers are actively investing in developing innovative HMO-based solutions, positioning the market for substantial growth as consumer awareness of these benefits continues to rise.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Human Milk Oligosaccharides (HMO) Market Size by Type & CAGR (2025-2032)

• Market Overview
• 2'FL
• 3'FL
• 3'SL
• 6'SL

Global Human Milk Oligosaccharides (HMO) Market Size by Product & CAGR (2025-2032)

• Market Overview
• Fucosyllactose
• Lnt & LNnt
• Sialyllactose

Global Human Milk Oligosaccharides (HMO) Market Size by Application & CAGR (2025-2032)

• Market Overview
• Infant formula
• Functional food & beverages
• Food supplements
• Health ingredients for human and animal
• Other

Global Human Milk Oligosaccharides (HMO) Market Size by Distribution channel & CAGR (2025-2032)

• Market Overview
• Hypermarkets and supermarkets
• Drug store or pharmacy
• Mass merchandiser
• Departmental stores
• Mono-brand stores
• Specialty stores
• Online sales channel

Global Human Milk Oligosaccharides (HMO) Market Size & CAGR (2025-2032)

• North America (Type, Product, Application, Distribution channel)
  • US
  • Canada
• Europe (Type, Product, Application, Distribution channel)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Type, Product, Application, Distribution channel)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Type, Product, Application, Distribution channel)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Type, Product, Application, Distribution channel)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• DSM (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BASF SE (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• DuPont (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nestle (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Inbiose NV (Belgium)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Gnubiotics Sciences S.A (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Royal FrieslandCampina N.V (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Elicityl S.A (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Dextra Laboratories (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Glycom A/S (Denmark)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Glycosyn (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medolac Laboratories (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Neolacta Lifesciences Pvt. Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Jennewein Biotechnologie GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lonza Specialty Ingredients (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Kirin Holdings Company (Kyowa Hakko Bio) (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ZuChem Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations